Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

There Are 'Tremendous Reasons to Be Hopeful' in Myeloma

Saturday, December 21, 2019

Myeloma treatment has drastically improved in recent years, leading to better outcomes, explained Sascha A. Tuchman, MD, MHS, associate professor at UNC Lineberger Comprehensive Cancer Center.


Myeloma has really gotten better and better over the last couple of decades. For a long time, there really wasn't much headway. Even if we think about the first chemotherapy regimen that came out in myeloma in the 50s and 60s, until the 90s, really not much changed over that 30-year period, despite a lot of oncology research. And really over the last 20 years now, novel agents have come out and every year almost, we get new drugs that are approved for myeloma. As a result of that, people are living longer than ever before. Therapy is more tolerable than ever before. And there's really tremendous reasons to be hopeful about the things that are here already that patients are enjoying new therapies that they're getting access to. Really the sky's the limit. There are things coming out now which are keeping myeloma under control for ever longer. Hopefully one of these things that we're working on in the clinic will eventually result in the cure for this. We're getting there. Maintain hope.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.